Recent findings suggest that microorganisms inhabiting the human body can influence the 1 development of cancer, but the role of microorganisms in bladder cancer pathogenesis has not 2 been explored yet. The aim of this study was to characterize and compare the urinary 3 microbiome of bladder cancer patients with those of healthy controls. Bacterial communities 4 present in urine specimens collected from male patients diagnosed with primary or recurrent, 5 non-muscle invasive bladder cancers, and from healthy, age-matched individuals were 6 analysed using 16S Illumina MiSeq sequencing. Our result show that the most abundant 7 phylum in both groups was Firmicutes, followed by Actinobacteria, Bacteroidetes and 8 Proteobacteria. While microbial diversity and overall microbiome composition were not 9 significantly different between bladder cancer and healthy samples, we identified specific 1 0 operational taxonomic units (OTUs) that were significantly more abundant (p < 0.05) in either 1 1 type of samples. Among those that were significantly enriched in the bladder cancer group, 1 2 we identified an OTU belonging to genus Fusobacterium, a possible protumorigenic 1 3 pathogen. Three OTUs more abundant in healthy urines were from genera Veillonella,
Introduction
Bladder cancer is the ninth most frequent malignant disease, with more than 160,000 deaths 2 per year reported globally. The risk of developing the disease increases with age, and it is 3 diagnosed three times more often in men than in women. Because majority of new cases are 4 found in people above 65 years of age due to increased life expectancy, it is anticipated that 5 the number of affected individuals will surge in the future 1 . 7 8 ( Fig. 3) . A PERMANOVA analysis was also performed to determine if there is a significant 7 9 association between microbiome composition and other tested variables such as malignancy, 8 0 cancer type or patient age. Among those, variations in the urine microbiome were 8 1 significantly associated only with age across all samples (p = 0.008). 8 2 Community structure reveals differently abundant OTUs in bladder cancer and healthy 8 3 urine 8 4 While there was no significant difference in microbiome composition in terms of overall 8 5 diversity or composition at the phylum or family level, specific OTUs were identified that 8 6 exhibited significant differences (p < 0.05) in abundance between cancer and healthy samples 8 7 ( Fig. 4) . Eight OTUs were enriched in urine of bladder cancer patients including genera 8 8 Fusobacterium, Actinobaculum, Facklamia, Campylobacter. Three OTUs identified at strain 8 9 level were Campylobacter hominis, Actinobaculum massiliense, and Jonquetella antropi 9 0 (94otu40402). Five OTUs were enriched in healthy samples from the genera Veillonella, 9 1 6 Streptococcus, Corynebacterium; these OTUs were further identified as Veillonella dispar at 9 2 species, and Streptococcus cristatus, Corynebacterium appendicis and Corynebacterium sp. at 9 3 strain level. 9 4 7 Discussion 9 5 In this study, we have characterized urinary microbial communities of male patients 9 6 diagnosed with primary or recurrent bladder cancer and compared it with those of disease 9 7 free, age-matched controls. Although we did not observe major differences in overall 9 8 microbiome profiles, we identified several OTUs that were significantly over-represented in 9 9 bladder cancer or healthy subgroup. These differences suggest a possible role for urinary 1 0 0 microbiome in bladder cancer pathogenesis that merits further evaluation. A reduction in microbial diversity in urine of bladder cancer patients was not detected in our diversity was found in urgency urinary incontinence 15 and chronic prostatitis 21 , while no changes in microbial diversity could be associated with overactive 12 or neuropathic bladder 1 0 7 symptomatology 18 . It may be that the abundance of specific bacteria in urine is more important than the total number of bacterial taxa present. The most abundant phylum in both bladder cancer and healthy group was Firmicutes, followed by Actinobacteria, Bacteroidetes and Proteobacteria (Fig. 2 ), which is in good Also, inter-individual variability, observed between microbiomes of the participants in our study, has been repeatedly demonstrated in publications on urinary microbiome 10, 11, 19, 20 , which makes it challenging to define what constitutes a 'core' bladder microbiome. Our comparison of bladder cancer versus healthy urine samples revealed bacterial taxa that 1 1 6 were overrepresented in one of the sample subgroups ( Fig. 4 ). Of note, among those OTUs that were more abundant in bladder cancer patients, an OTU belonging to genus 1 1 8 Fusobacterium was detected. Fusobacterium is a common constituent of oral microbiome, but 1 1 9 also an opportunistic pathogen with recognized carcinogenic potential 25, 26 . It has been found 1 2 0 associated with colorectal cancer in several studies 27, 28, 29, 30 . Fusobacterial DNA was also 1 2 1 detected in pancreatic 31 , breast 32 , esophageal 33 and laryngeal 34 cancer tissue, but this is to our
knowledge, the first report on association of Fusobacterium with urothelial carcinomas. A proposed mechanism by which Fusobacterium nucleatum drives tumorigenesis involves
activation of β -catenin cell signalling pathway leading to cell proliferation 35, 36 . A study by 1 2 5 Kostić et al. 37 , based on human sample analysis and mice model, suggests that, through environment which supports tumour progression. There is also evidence that F. nucleatum 1 2 8 inhibits NK cell cytotoxicity and T cell activity, thereby promoting immune evasion, which is
one of the hallmarks of cancer 38 .
Enrichment of F. nucleatum in cancerous tissue seems to be mediated by binding of (Gal-GalN Ac) 39 . A recently published pilot study demonstrated that in addition to colorectal Gal-GalNAc were found in urothelial carcinomas, the microbiome analysis undertaken in our 1 3 5 study suggests that bladder cancer tissue can also be colonized by F. nuclatum.
An interesting observation on F. nucleatum is not to be overlooked: through action of its bacterial metabolites, F. nucleatum may be able to reactivate latent viral infections. In herpesvirus 41 , which we found was associated with bladder cancer in our previous study 42 .
This indicates a possible synergistic interplay of bacterial and viral pathogens in bladder
The most prominent OTU enriched in bladder cancer urines in our study ( Fig. 4) together with Fusobacterium in colorectal cancer 43 and esophageal biopsies 44 .
Amongst other OTUs that were significantly more abundant in cancer patients, an OTU characteristic of urine microbiomes from individuals aged 70 and older 10 . Given the relatively
small sample size, it is interesting that we could note clustering of samples according to age composition of microbial communities in both the bladder and the gut 10 . Whether these shifts 1 5 4 in microbiome composition that occur with aging increase cancer risks remains to be 1 5 5
investigated. Apart from being oncogenic, commensal microbiota may also provide beneficial, tumour- suppressive effects to the human host 7 . The concept that specific bacteria could protect urinary bladder cancer, because this is the only malignancy treated by a live microorganism, Mycobacterium bovis bacille Calmette-Guérin (BCG). Despite being used for more than 40 model suggests that BCG attaches to urothelial cells, which is followed by BCG internalization by bladder cancer cells and initiation of immune responses that destroy 1 6 4 cancerous tissue 45 .
It could be envisioned that similarly to BCG, certain commensal bacteria, residing naturally in 1 6 6 the healthy bladder, could serve the function of tumour surveillance or act beneficially in a 1 6 7 different manner. In this study, five OTUs were found to be increased in healthy bladder and a lesser extent Veillonella, have repeatedly been observed in urine of healthy men 9, 19, 46 . In malignancy, prostate cancer, also showed the statistically significant enrichment of Streptococcus in nontumorous tissue 47 . Corynebacterium might be a typical urine component 1 7 3 in healthy men as opposed to Lactobacillus which is prevalent in women 19 . Our study on bladder cancer microbiome had some limitations. We used clean-catch midstream urine to sample bladder microbiome, which has its limitations but from an ethical point of view is a far less invasive method then bladder tissue biopsy or catheterization. This study included only male patients. Men are at considerably higher risk of developing 1 7 8 bladder cancer, which may be explained by the effects of sex hormones or gender differences 1 7 9 in metabolic detoxification of carcinogens 48, 49 . It would be interesting to explore if any species, provides a protective effect. As with other studies comparing disease versus healthy microbiome, it is not possible to say whether the microbial alterations are the cause or the consequence of the disease. Further longitudinal studies with a larger sample number at different stages of tumorigenesis and animal model studies will be needed to clarify the role of microbiome in bladder cancer 1 8 6 formation and progression. 1 8 7 The main strength of the study is the novel insight on subtle changes of urinary microbiome in species. Additionally, these results are important because the male urinary microbiome is
often overlooked in urological studies, as the field is much more focused on female urogenital pathologies. More studies like this are needed to further define the core microbiome in both sexes and evaluate how it changes in specific disease states. In conclusion, the 16S rDNA gene sequencing-based approach used in this work enabled us to 1 9 4 characterize urinary bladder microbiome and detect differences in the relative abundance of representative. Whether observed differences contribute to bladder cancer development 1 9 7 remains to be elucidated. A better understanding of the role of microbiome in bladder cancer 1 9 8 could direct urologists to novel diagnostic and prognostic options, as well as to more personalized treatments and microbiome-targeted therapeutic interventions. The study began following approval from the Ethics Committee of the University Hospital in Split. Thirty six Caucasian men were recruited at the Department of Urology, University Table S1 ). All experiments were performed in accordance with relevant guidelines and regulations and participants gave written informed consent for urine collection and analysis for research purposes. Exclusion criteria for both groups were antibiotic usage for at least one infections, diabetes and obesity. Additional exclusion criteria for bladder cancer patients were at -80ºC. DNA isolation from urine 2 1 8 Urine specimens (30 ml) were thawed and centrifuged at 7500 g, 4 °C for 10 minutes. The pellet was used for DNA extraction using PowerSoil @ DNA Isolation Kit (MoBio Laboratories, Inc.), performed according to manufacturer's protocol. To avoid environmental were carried out within a PCR hood. Isolated DNA samples were placed at -20 °C until PCR (Invitrogen, Life Technologies). 16S rRNA gene library preparation and MiSeq sequencing 2 2 6 PCR amplification of 16S rDNA, sequencing and analyses were performed by Second Genome. 16S rRNA gene V4 region was amplified with 515F-806R fusion primers that incorporate Illumina adapters and indexing barcodes 50 . PCR products were quantified using Quant-iT™ PicoGreen™ dsDNA Assay Kit from Invitrogen (Life Technologies, Grand
Island, NY), pooled in equal molar ratios, and sequenced for 2 x 250 cycles on the Illumina MiSeq platform (Illumina, San Diego, CA). Bioinformatics and statistical analyses 2 3 3 Sequenced paired-end reads were processed using USEARCH 51 . All sequences hitting a 2 3 4 unique strain in an in-house strains database with an identity ≥ 99% were assigned a strain Operational Taxonomic Unit (OTU). The remaining non-strain sequences were quality filtered, dereplicated and then clustered at 97% by UPARSE 52 that were observed in less than 10% of the sample set. Diversity within samples (alpha diversity) was evaluated as richness and Shannon diversity. Richness is the number of observed unique Operational Taxonomic Units (OTUs), and between samples (beta diversity) was assessed using the Bray-Curtis dissimilarity measure 55 . To visualize inter-sample relationships, Principal Coordinates Analysis (PCoA) was performed. Differences in the overall microbial composition between bladder cancer and healthy samples Both alpha diversity metrics were statistically similar between cancer and healthy samples. Permutational analysis of variance shows that variations in the urine microbiome were significantly associated with age (p = 0.008). Samples do not cluster according to their cancer/healthy status. 94otu4042 was identified as Jonquetella anthropi, while 94otu9391 and 94otu11945 belong to family Ruminococcaceae. Features were considered significant if their false discovery ratecorrected p-value was less than or equal to 0.05, and the absolute value of the log2 fold change was greater than or equal to 1.
